Frontiers in Oncology
Clinical Biomarker-Derived Biological Age and Prevalent Breast Cancer: Observational Analyses and Complementary Mendelian Randomization of Epigenetic Age Acceleration
Accepted, not yet published: cross-sectional study of 6,573 peopleGrimAge